8-K
filed November 7, 2023, 6:59 PM ET
ticker SGRY
CIK 0001638833
earnings
confidence high
sentiment positive
materiality 0.80
Surgery Partners Q3 revenue up 8.6% to $674M; raises FY Adjusted EBITDA guidance to $436-440M
Surgery Partners, Inc.
2023-Q3 EPS reported
-$0.09
revenue$2,007,900,000
- Revenues $674.1M (+8.6% YoY); net loss improved to $4.9M from $25M.
- Adjusted EBITDA $105.5M (+9.7% YoY); margin improved to 15.7%.
- Same-facility revenues up 14.2% (days adjusted); case volume +2.9%, revenue per case +11.0%.
- Full-year 2023 Adjusted EBITDA guidance raised to $436-440M; revenue ~$2.75B.
- Free Cash Flow of $63.2M in Q3; cash and revolver availability $781M total.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Surgery Partners, Inc. reported 2023 results: revenue approximately $2.75 billion. Guidance raised.
- Period
- 2023
- Revenue
- approximately $2.75 billion
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
The Company raised projected 2023 Adjusted EBITDA to a range of $436 million to $440 million and anticipates revenue at approximately $2.75 billion.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Surgery Partners, Inc. reported year-to-date 2023 results: revenue $2,007.9 million, net income $10.9 million.
- Period
- year-to-date 2023
- Revenue
- $2,007.9 million
- Net income
- $10.9 million
- Result
- reported results
Exact text from the filing
respectively, compared to $25.0 million and $96.2 million, respectively, for the same period last year. Year-to-Date 2023 Results Revenues year-to-date 2023 increased 9.6% to $2,007.9 million from $1,832.2 million for the 2022 period. Days adjusted same-facility revenues for year-to-date 2023 increased 10.6% from the same period last year, with an increase in revenue
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Surgery Partners, Inc. reported third quarter ended September 30, 2023 results: revenue $674.1 million, net income $4.9 million.
- Period
- third quarter ended September 30, 2023
- Revenue
- $674.1 million
- Net income
- $4.9 million
- Result
- reported results
Exact text from the filing
Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. • Revenues were $674.1 million representing 8.6% growth • Days Adjusted Same-facility revenues increased 14.2% • Net loss attributable to Surgery Partners was $4.9 million • Adjusted EBITDA was $105.5 million,
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.